EMA Human Scientific Committees' Working Parties with Patients' and Consumers' Organisations (PCWP) and Healthcare Professionals' Organisations (HCPWP) joint meeting
Date:
27/06/2017 to 28/06/2017
Location:
European Medicines Agency, London, UK
This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. On June 27, EUnetHTA speakers will join the meeting to present on their activities and discuss areas of collaboration with patients and healthcare professionals; on June 28 there will be a presentation on the European Commission's report on the shortcomings of product information followed by a discussion on the implementation of the report's recommendations. Also during the two-day meeting, participants will learn about the HMA/EMA Taskforce on availability of authorised medicines and discuss their involvement in the Pharmacovigilance additional monitoring impact analysis; other topics for discussion include a proposal for revision of PCWP/HCPWP mandates and rules of procedure, the principles and practical considerations for streamlining the process for re-assessment of eligibility status, and the drafting process for a joint 2018/19 Work Plan.
-
List item
Agenda - EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (27 June 2017) (PDF/99.33 KB)
Adopted
First published: 06/06/2017
Last updated: 26/09/2017
EMA/213892/2017 -
List item
List of participants - EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (27 June 2017) (PDF/102.35 KB)
First published: 26/09/2017
Last updated: 26/09/2017
EMA/258524/2017 -
List item
Minutes - EMA Human Scientific Committees' Working Parties with Patients’ and Consumers’ Organisations (PCWP) and Healthcare Professionals’ Organisations (HCPWP) joint meeting (27 June 2017) (PDF/216.32 KB)
First published: 26/09/2017
Last updated: 26/09/2017
EMA/355452/2017 -
List item
Presentation - Conditional marketing authorisation - Report on ten years of experience at the EMA (Zigmars Sebris, EMA) (PDF/546.76 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - Patient and Healthcare Professional Involvement in EUnetHTA Activities (Michelle Mujoomdar) (PDF/543.67 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - HMA/EMA Taskforce on availability of authorised medicines (Brendan Cuddy, EMA) (PDF/447.61 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - PRIME: One year experience and highlights from 19 May stakeholder meeting (Zahra Hanaizi, Jordi Llinares, EMA) (PDF/498.38 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - Survey to estimate patients and HCP awareness of the additional monitoring concept (Justina Januskiene, EMA) (PDF/95.67 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - EMA framework of collaboration with academia (Monica Ensini, EMA) (PDF/678.85 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - HCPWP/PCWP feedback from CHMP (Fà¡tima Ventura, EMA) (PDF/324 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - Committee for Advanced Therapies (CAT) update (Kieran Breen) (PDF/539.03 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - Committee on Herbal Medicinal Products (HMPC) update (Steinar Madsen) (PDF/158.68 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - Pharmacovigilance Risk Assessment Committee (PRAC) update (Raymond Anderson) (PDF/199.41 KB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - Patient Access Partnership (Stanimir Hasardzhiev, PACT) (PDF/1.26 MB)
First published: 26/09/2017
Last updated: 26/09/2017 -
List item
Presentation - The Commission report on SmPC and package leaflet for medicinal products for human use (K.Kurgonaite) (PDF/331.39 KB)
First published: 26/09/2017
Last updated: 26/09/2017